External Advisory Board
The External Scientific Advisory Board, which consists of national experts in basic, clinical and population-based research, participates in an annual external scientific review of the Masonic Cancer Center's activities.
Kevin Cullen, MD - Chairperson
Director, University of Maryland Greenebaum Cancer Center, Baltimore, MD.
Alan Ashworth, PhD, FRS
Director, University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center.
David Beer, PhD
Co-Director, Cancer Genetics Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
Smita Bhatia, MD, MPH
Associate Director for Outcomes Research, UAB Comprehensive Cancer Center, Birmingham, AL
MaryAnn Bjornsti, PhD
Associate Director for Translational Research, University of Alabama Birmingham Comprehensive Cancer Center.
Melissa Bondy, PhD
Professor, Department of Epidemiology, M.D. Anderson Cancer Center, Houston, TX.
Michael Darling, MHA
Associate Director for Administration, Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN.
Stan Gerson, MD
Director, Case Comprehensive Cancer Center, Cleveland, OH.
Thomas Kensler, PhD
Co-leader for the Cancer Epidemiology and Prevention Program at the University of Pittsburgh Cancer Institute, Pittsburgh, PA.
James Mulé, PhD
Associate Center Director, Translational Science & Technology Development, Moffitt Cancer Center, Tampa, FL.
Vito Quaranta, MD
Professor of Cancer Biology, Vanderbilt-Ingram Cancer Center, Nashville, TN.
Scott Ramsey, MD, PhD
Director, Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA.
Thomas Sellers, PhD, MPH
Center Director and Executive Vice President, Moffitt Cancer Center, Tampa, FL.
Louis Weiner, MD
Director, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC.
Community Advisory Board
The Community Advisory Board advises and supports the leadership in mission, programmatic direction, community interactions, outreach, public relations, and advocacy.